Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Aug;94(2):731–740. doi: 10.1172/JCI117392

Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.

B Crestani 1, P Cornillet 1, M Dehoux 1, C Rolland 1, M Guenounou 1, M Aubier 1
PMCID: PMC296153  PMID: 8040328

Abstract

The aims of this study were (a) to determine if rat alveolar type II (ATII) cells and human pulmonary epithelial-derived cells (A549 cell line) could generate IL-6 in vitro, (b) to characterize the cytokine regulation of IL-6 gene and protein expression in these cells, and (c) to detect the in vivo expression of immunoreactive IL-6 by human ATII cells. Rat ATII cells in primary culture secreted bioactive IL-6 and immunostained with an anti-IL-6 antiserum. Spontaneous IL-6 secretion by rat ATII cells amounted to 5,690 +/- 770 pg/ml/10(6) cells (n = 12) and was fivefold higher than spontaneous rat alveolar macrophages IL-6 secretion (1,052 +/- 286 pg/ml/10(6) cells, n = 8, P = 0.001). Rat alveolar macrophage conditioned media (CM) increased IL-6 secretion by rat ATII cells through the effect of IL-1 and TNF. IL-6 gene expression and IL-6 secretion by A549 cells was induced by IL-1 beta, TNF alpha, and by human alveolar macrophages and THP1 cells CM. Induction was abolished when CM were preincubated with anti-IL-1 beta and anti-TNF alpha antibody. The combination of IFN gamma and LPS induced the expression of IL-6 mRNA by A549 cells whereas LPS alone had no effect. Immunohistochemical staining evidenced the expression of immunoreactive IL-6 by hyperplastic ATII cells in fibrotic human lung, a condition in which alveolar macrophages are known to be activated. ATII cells in normal human lung did not express immunoreactive IL-6. Our findings demonstrate that ATII cells may be an important source of IL-6 in the alveolar space thereby participating to the regulation of the intra-alveolar immune response.

Full text

PDF
731

Images in this article

734Image
on p.734
734Image
on p.734
736Image
on p.736
736Image
on p.736
736Image
on p.736
736Image
on p.736
737Image
on p.737
737Image
on p.737
738Image
on p.738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990 Aug;4(11):2860–2867. [PubMed] [Google Scholar]
  3. Antoniades H. N., Bravo M. A., Avila R. E., Galanopoulos T., Neville-Golden J., Maxwell M., Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest. 1990 Oct;86(4):1055–1064. doi: 10.1172/JCI114808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ayars G. H., Altman L. C., Rosen H., Doyle T. The injurious effect of neutrophils on pneumocytes in vitro. Am Rev Respir Dis. 1984 Jun;129(6):964–973. doi: 10.1164/arrd.1984.129.6.964. [DOI] [PubMed] [Google Scholar]
  5. Boutten A., Dehoux M., Deschenes M., Rouzeau J. D., Bories P. N., Durand G. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol. 1992 Oct;22(10):2687–2695. doi: 10.1002/eji.1830221032. [DOI] [PubMed] [Google Scholar]
  6. Chin Y. H., Cai J. P., Johnson K. Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. J Immunol. 1990 Dec 1;145(11):3669–3677. [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Cott G. R., Westcott J. Y., Voelkel N. F. Prostaglandin and leukotriene production by alveolar type II cells in vitro. Am J Physiol. 1990 Apr;258(4 Pt 1):L179–L187. doi: 10.1152/ajplung.1990.258.4.L179. [DOI] [PubMed] [Google Scholar]
  9. Crapo J. D., Barry B. E., Foscue H. A., Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis. 1980 Jul;122(1):123–143. doi: 10.1164/arrd.1980.122.1.123. [DOI] [PubMed] [Google Scholar]
  10. Crapo J. D., Barry B. E., Gehr P., Bachofen M., Weibel E. R. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982 Aug;126(2):332–337. doi: 10.1164/arrd.1982.126.2.332. [DOI] [PubMed] [Google Scholar]
  11. Crestani B., Rolland C., Petiet A., Colas-Linhart N., Aubier M. Cell surface carbohydrates modulate neutrophil adherence to alveolar type II cells in vitro. Am J Physiol. 1993 Apr;264(4 Pt 1):L391–L400. doi: 10.1152/ajplung.1993.264.4.L391. [DOI] [PubMed] [Google Scholar]
  12. Cromwell O., Hamid Q., Corrigan C. J., Barkans J., Meng Q., Collins P. D., Kay A. B. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology. 1992 Nov;77(3):330–337. [PMC free article] [PubMed] [Google Scholar]
  13. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol. 1990 Oct;259(4 Pt 1):L159–L184. doi: 10.1152/ajplung.1990.259.4.L159. [DOI] [PubMed] [Google Scholar]
  14. Dobbs L. G. Isolation and culture of alveolar type II cells. Am J Physiol. 1990 Apr;258(4 Pt 1):L134–L147. doi: 10.1152/ajplung.1990.258.4.L134. [DOI] [PubMed] [Google Scholar]
  15. Edelson J. D., Shannon J. M., Mason R. J. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis. 1988 Nov;138(5):1268–1275. doi: 10.1164/ajrccm/138.5.1268. [DOI] [PubMed] [Google Scholar]
  16. Elias J. A., Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol. 1990 Jul 1;145(1):161–166. [PubMed] [Google Scholar]
  17. Grigg J. M., Barber A., Silverman M. Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):782–786. doi: 10.1164/ajrccm/145.4_Pt_1.782. [DOI] [PubMed] [Google Scholar]
  18. Hack C. E., De Groot E. R., Felt-Bersma R. J., Nuijens J. H., Strack Van Schijndel R. J., Eerenberg-Belmer A. J., Thijs L. G., Aarden L. A. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989 Oct;74(5):1704–1710. [PubMed] [Google Scholar]
  19. Hahon N., Castranova V. Interferon production in rat type II pneumocytes and alveolar macrophages. Exp Lung Res. 1989 May;15(3):429–445. doi: 10.3109/01902148909087869. [DOI] [PubMed] [Google Scholar]
  20. Haies D. M., Gil J., Weibel E. R. Morphometric study of rat lung cells. I. Numerical and dimensional characteristics of parenchymal cell population. Am Rev Respir Dis. 1981 May;123(5):533–541. doi: 10.1164/arrd.1981.123.5.533. [DOI] [PubMed] [Google Scholar]
  21. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990 Dec;11(12):443–449. doi: 10.1016/0167-5699(90)90173-7. [DOI] [PubMed] [Google Scholar]
  22. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986 Nov 6;324(6092):73–76. doi: 10.1038/324073a0. [DOI] [PubMed] [Google Scholar]
  23. Humbert M., Devergne O., Cerrina J., Rain B., Simonneau G., Dartevelle P., Duroux P., Galanaud P., Emilie D. Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations. Am Rev Respir Dis. 1992 May;145(5):1178–1184. doi: 10.1164/ajrccm/145.5.1178. [DOI] [PubMed] [Google Scholar]
  24. Jones K. P., Reynolds S. P., Capper S. J., Kalinka S., Edwards J. H., Davies B. H. Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects. Clin Exp Immunol. 1991 Jan;83(1):30–34. doi: 10.1111/j.1365-2249.1991.tb05583.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kawanami O., Ferrans V. J., Crystal R. G. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest. 1982 Jan;46(1):39–53. [PubMed] [Google Scholar]
  26. Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K. C., Kemp A., Bereznay O. H., Greenberg A. H. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991 Aug;5(2):155–162. doi: 10.1165/ajrcmb/5.2.155. [DOI] [PubMed] [Google Scholar]
  27. Kotloff R. M., Little J., Elias J. A. Human alveolar macrophage and blood monocyte interleukin-6 production. Am J Respir Cell Mol Biol. 1990 Nov;3(5):497–505. doi: 10.1165/ajrcmb/3.5.497. [DOI] [PubMed] [Google Scholar]
  28. Krueger J., Ray A., Tamm I., Sehgal P. B. Expression and function of interleukin-6 in epithelial cells. J Cell Biochem. 1991 Apr;45(4):327–334. doi: 10.1002/jcb.240450404. [DOI] [PubMed] [Google Scholar]
  29. Mason R. J., Williams M. C. Type II alveolar cell. Defender of the alveolus. Am Rev Respir Dis. 1977 Jun;115(6 Pt 2):81–91. doi: 10.1164/arrd.1977.115.S.81. [DOI] [PubMed] [Google Scholar]
  30. May L. T., Torcia G., Cozzolino F., Ray A., Tatter S. B., Santhanam U., Sehgal P. B., Stern D. Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun. 1989 Mar 31;159(3):991–998. doi: 10.1016/0006-291x(89)92206-7. [DOI] [PubMed] [Google Scholar]
  31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  32. Paine R., 3rd, Chavis A., Gaposchkin D., Christensen P., Mody C. H., Turka L. A., Toews G. B. A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase. Am J Respir Cell Mol Biol. 1992 Jun;6(6):658–666. doi: 10.1165/ajrcmb/6.6.658. [DOI] [PubMed] [Google Scholar]
  33. Paine R., 3rd, Mody C. H., Chavis A., Spahr M. A., Turka L. A., Toews G. B. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol. 1991 Sep;5(3):221–229. doi: 10.1165/ajrcmb/5.3.221. [DOI] [PubMed] [Google Scholar]
  34. Parra S. C., Burnette R., Price H. P., Takaro T. Zonal distribution of alveolar macrophages, type II pneumonocytes, and alveolar septal connective tissue gaps in adult human lungs. Am Rev Respir Dis. 1986 May;133(5):908–912. [PubMed] [Google Scholar]
  35. Perlmutter D. H., May L. T., Sehgal P. B. Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest. 1989 Jul;84(1):138–144. doi: 10.1172/JCI114133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rothman B. L., Merrow M., Despins A., Kennedy T., Kreutzer D. L. Effect of lipopolysaccharide on C3 and C5 production by human lung cells. J Immunol. 1989 Jul 1;143(1):196–202. [PubMed] [Google Scholar]
  37. Sanceau J., Beranger F., Gaudelet C., Wietzerbin J. IFN-gamma is an essential cosignal for triggering IFN-beta 2/BSF-2/IL-6 gene expression in human monocytic cell lines. Ann N Y Acad Sci. 1989;557:130-41, discussion 141-3. [PubMed] [Google Scholar]
  38. Sanceau J., Wijdenes J., Revel M., Wietzerbin J. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol. 1991 Oct 15;147(8):2630–2637. [PubMed] [Google Scholar]
  39. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  40. Simon R. H., DeHart P. D., Todd R. F., 3rd Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest. 1986 Nov;78(5):1375–1386. doi: 10.1172/JCI112724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Soliman D. M., Twigg H. L., 3rd Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol. 1992 Oct;263(4 Pt 1):L471–L478. doi: 10.1152/ajplung.1992.263.4.L471. [DOI] [PubMed] [Google Scholar]
  42. Standiford T. J., Kunkel S. L., Basha M. A., Chensue S. W., Lynch J. P., 3rd, Toews G. B., Westwick J., Strieter R. M. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest. 1990 Dec;86(6):1945–1953. doi: 10.1172/JCI114928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Standiford T. J., Kunkel S. L., Phan S. H., Rollins B. J., Strieter R. M. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991 May 25;266(15):9912–9918. [PubMed] [Google Scholar]
  44. Strunk R. C., Eidlen D. M., Mason R. J. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest. 1988 May;81(5):1419–1426. doi: 10.1172/JCI113472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tanner J., Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest. 1991 Jul;88(1):239–247. doi: 10.1172/JCI115283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tazi A., Bouchonnet F., Grandsaigne M., Boumsell L., Hance A. J., Soler P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest. 1993 Feb;91(2):566–576. doi: 10.1172/JCI116236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ulich T. R., Yin S., Guo K., Yi E. S., Remick D., del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991 May;138(5):1097–1101. [PMC free article] [PubMed] [Google Scholar]
  48. Vignaud J. M., Allam M., Martinet N., Pech M., Plenat F., Martinet Y. Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. Am J Respir Cell Mol Biol. 1991 Dec;5(6):531–538. doi: 10.1165/ajrcmb/5.6.531. [DOI] [PubMed] [Google Scholar]
  49. Zhou D., Munster A., Winchurch R. A. Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. FASEB J. 1991 Aug;5(11):2582–2585. doi: 10.1096/fasebj.5.11.1868982. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES